申请人:Anacor Pharmaceuticals, Inc.
公开号:US10669291B2
公开(公告)日:2020-06-02
This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
除其他外,本发明还提供了用于治疗原生动物感染的新型化合物、含有此类化合物的药物组合物,以及这些化合物与至少一种额外的治疗有效药物的组合物。